(3-((4-Fluorobenzyl)oxy)phenyl)boronic acid – (1072952-03-4)

ofloxacin, 82419-36-1, Floxin, Ofloxacine, Tarivid, Ocuflox, Oxaldin, Ofloxacino, Oflocet, Visiren, Ofloxacinum, DL-8280, Hoe-280, OFLX, Ofloxacina, Exocin, Floxin otic, Ofloxacin Otic, HOE 280, Ofloxacinum [Latin], FLOXIN IN DEXTROSE 5%, 83380-47-6, 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3, 7-dihydro-2H-[1, 4]oxazino[2, 3, 4-ij]quinoline-6-carboxylic acid, MFCD00226105, ORF 18489, CCRIS 5233, CHEBI:7731, UNII-A4P49JAZ9H, A4P49JAZ9H, NSC-727071, NSC-758178, Exocin (eye drops), BRN 3657947, 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2, 3-dihydro-7H-[1, 4]oxazino[2, 3, 4-ij]quinoline-6-carboxylic acid, DTXSID3041085, FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER, HSDB 8030, CHEMBL4, J01MA01, Dextrofloxacin, MLS000028749, 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05, 13]trideca-5(13), 6, 8, 11-tetraene-11-carboxylic acid, DTXCID1021085, NSC727071, Ofloxacinum (Latin), NSC 727071, NSC 758178, Ofloxacin [USAN:USP:INN:BAN:JAN], 8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2, 3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid, OFX, Ofloxacina [DCIT], Ofloxacine [French], Exocine, Flobacin, Ofloxacin 100 microg/mL in Acetonitrile, SMR000058192, Zanocin, Floxil, Ofloxacino [Spanish], OFLOXACIN (MART.), OFLOXACIN [MART.], OFLOXACIN (USP-RS), OFLOXACIN [USP-RS], (+-)-9-Fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1, 2, 3-de)(1, 4)benzoxazin-6-carbonsaeure, 7H-Pyrido(1, 2, 3-de)-1, 4-benzoxazine-6-carboxylic acid, 2, 3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (+-)-, 7H-Pyrido(1, 2, 3-de)-1, 4-benzoxazine-6-carboxylic acid, 9-fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (+-)-, OFLOXACIN (EP MONOGRAPH), OFLOXACIN [EP MONOGRAPH], OFLOXACIN (USP MONOGRAPH), OFLOXACIN [USP MONOGRAPH], DL 8280, MFCD00865049, PT 01, Ofloxacin (USAN:USP:INN:BAN:JAN), 7-Fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05, 13]trideca-5, 7, 9(13), 11-tetraene-11-carboxylic acid, 9-FLUORO-2, 3-DIHYDRO-3-METHYL-10-(4-METHYL-1-PIPERAZINYL)-7-OXO-7H-PYRIDO(1, 2, 3-DE)(1, 4)BENZOXAZINE-6-CARBOXYLIC ACID, DL-, Floxin (TN), (+/-)-Floxin, SR-01000076050, Hoe280, Monoflocet, Ofloxaxin, DL-ofloxacin, NCGC00016948-01, (-)-(S)-9-Fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1, 2, 3-de]-1 (-)-(S)-9-Fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1, 2, 3-de]-1, (S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3, 7-dihydro-2H-[1, 4]oxazino[2, 3, 4-ij]quinoline-6-carboxylic acid, 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2, 3-dihydro-7H-(1, 4)oxazino(2, 3, 4-ij)quinoline-6-carboxylic acid, Ofloxacin (Floxin), Ofloxacin Ophthalmic, Olfoxacin Otic Soln, CAS-82419-36-1, DL8280, Ofloxacin Ophth Soln, Ofloxacin (Standard), (+-)-9-Fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1, 2, 3-de)-1, 4-benzoxazine-6-carboxylic acid, WP-0405, Levofloxacin-13C-D3, Spectrum_001186, OFLOXACIN [INN], OFLOXACIN [JAN], OFLOXACIN [MI], OFLOXACIN [USAN], Opera_ID_1114, Prestwick0_000237, Prestwick1_000237, Prestwick2_000237, Prestwick3_000237, Spectrum2_001464, Spectrum3_001499, Spectrum4_000324, Spectrum5_001063, OFLOXACIN [VANDF], Epitope ID:116889, O 8757, OFLOXACIN [WHO-DD], Lopac0_000904, Oprea1_242882, SCHEMBL24373, BSPBio_000313, BSPBio_003117, KBioGR_000667, KBioSS_001666, fluoro-methyl-(4-methylpiperazin-1-yl)-oxo-[?]carboxylic acid, MLS001074203, MLS006011774, DivK1c_000721, SPECTRUM1502044, SPBio_001387, SPBio_002234, (S)-Ofloxacin Levaquin Quixin, Ofloxacin (JP18/USP/INN), BPBio1_000345, OFLOXACIN [ORANGE BOOK], SCHEMBL14163982, GTPL10918, HMS502E03, HY-B0125R, KBio1_000721, KBio2_001666, KBio2_004234, KBio2_006802, KBio3_002617, S01AE01, S02AA16, CHEBI:194135, NINDS_000721, HMS1568P15, HMS1921H12, HMS2090F07, HMS2092B10, HMS2095P15, HMS2235C05, HMS3259G07, HMS3262F10, HMS3369B01, HMS3393K06, HMS3604B17, HMS3712P15, Pharmakon1600-01502044, (3R)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2, 3-dihydro-7H-[1, 4]oxazino[2, 3, 4-ij]quinoline-6-carboxylic acid, BCP14346, BCP22048, HY-B0125, RKL10083, UYB17021, Ofloxacin, fluoroquinolone antibiotic, Tox21_110703, Tox21_500904, BBL005605, BDBM50045004, CCG-39210, NSC758178, s1463, STK256723, AKOS001033517, AKOS016042783, Ofloxacine DL-8280 HOE-280, Tox21_110703_1, 1ST5740, AC-7616, AO26535, BCP9000851, CS-1891, DB01165, KS-5011, LP00904, NC00466, SDCCGSBI-0050879.P004, IDI1_000721, NCGC00015772-02, NCGC00015772-03, NCGC00015772-04, NCGC00015772-05, NCGC00015772-06, NCGC00015772-07, NCGC00015772-08, NCGC00015772-09, NCGC00015772-10, NCGC00015772-12, NCGC00015772-13, NCGC00015772-22, NCGC00094219-01, NCGC00094219-02, NCGC00094219-03, NCGC00094219-04, NCGC00094219-05, NCGC00094219-06, NCGC00178284-01, NCGC00178284-02, NCGC00261589-01, (+/-)-9-Fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1, 2, 3-de]-1, 4-benzoxazine-6-carboxylic acid, 9-Fluoro-3, 7-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2H-[1, 4]oxazino[2, 3, 4-ij]quinoline-6-carboxylic Acid, SY007392, SY052697, SBI-0050879.P003, DB-056608, AB00513820, EU-0100904, NS00098749, O0403, EN300-06482, Ofloxacin, VETRANAL(TM), analytical standard, VU0243192-7, C07321, D00453, AB00052263-12, AB00052263-13, AB00052263_14, AB00052263_15, Q411447, SR-01000076050-1, SR-01000076050-4, SR-01000076050-7, BRD-A24228527-001-05-9, BRD-A24228527-001-19-0, BRD-A24228527-001-31-5, BRD-A24228527-213-01-9, SR-01000076050-16, Z56761309, F0020-0095, F0472-0226, 138199-71-0 (0.5H2O), Ofloxacin, European Pharmacopoeia (EP) Reference Standard, Ofloxacin, United States Pharmacopeia (USP) Reference Standard, (+/-)-9-Fluoro-2, 2, 3-de)-1, 4-benzoxazine-6-carboxylic acid, Ofloxacin, Pharmaceutical Secondary Standard Certified Reference Material, (+/-)-9-Fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1, 2, 3-de]-1, 4-benzoxazine-6-carboxylic acid, (+/-)-9-Fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7–oxo-7H-pyrido(1, 2, 3-de)–1, 4-benzoxazine-6-carboxylic acid, (3RS)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2, 3-dihydro-7H-pyrido(1, 2, 3-de)(1, 4)benzoxazine-6-carboxylic acid, 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0, 5, 13]trideca-5(13), 6, 8, 11-tetraene-11-carboxylic acid, 7H-Pyrido(1, 2, 3-de)-1, 4-benzoxazine-6-carboxylic acid, 9-fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, 7H-PYRIDO(1, 2, 3-DE)-1, 4-BENZOXAZINE-6-CARBOXYLIC ACID, 9-FLUORO-2, 3-DIHYDRO-3-METHYL-10-(4-METHYL-1-PIPERAZINYL)-7-OXO-, (+/-)-, 9-Fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1, 2, 3-de]-1, 4-benzoxazine-6-carboxylic acid, 9-Fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1, 2, 3-de]-1, 4-benzoxazine-6-carboxylic acid Ofloxacine DL- 8280, 9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2, 3-dihydro-7H-pyrido [1, 2, 3-de]-1, 4-Benzoxazin-6-carboxylic Acid, 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2, 3-dihydro-7H-pyrido[1, 2, 3-de][1, 4]benzoxazine-6-carboxylic acid, 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3, 7-dihydro-2H-[1, 4]oxazino[2, 3, 4-ij]quinoline-6-carboxylicacid, 9-fluoro-3-methyl-10-(4-methylpiperazino)-7-oxo-2, 3-dihydro-7H-[1, 4]oxazino[2, 3, 4-ij]quinoline-6-carboxylic acid